The invention relates to vaginal composition comprising a combination of estrogen and vitamin D or a vitamin D analog at a daily dosage delivery of (i) estrogen ranging from 2 µg to 10 µg estrogen of estradiol equivalent and (ii) vitamin D or analog ranging from 7.5 µg to 100 µg of vitamin D equivalent.